News

UCSF Helps Launch NIH Precision Medicine Cohort Program

UCSF Helps Launch NIH Precision Medicine Cohort Program

October 13, 2016

UC San Francisco is helping to launch a landmark effort by the National Institutes of Health to engage 1 million or more U.S. participants in research aimed at preventing and treating disease based on individual differences in lifestyle, environment and genetics.

Advances in breast cancer research and treatment bring hope

Advances in breast cancer research and treatment bring hope

October 12, 2016

Scientists across the University of California system are taking aim at breast cancer. Along with developing better detection methods, researchers are making advances in imaging techniques and tapping into advances in genetics and immunology to develop more refined approaches to treatment.

Beating breast cancer: The latest on prevention and screening

Beating breast cancer: The latest on prevention and screening

October 4, 2016

There’s good news on the breast cancer front: Advances in medicine are helping more women than ever survive a breast cancer diagnosis.

Seven UCSF Scientists Receive NIH ‘Blue-Sky’ Research Awards

Seven UCSF Scientists Receive NIH ‘Blue-Sky’ Research Awards

October 4, 2016

The National Institutes of Health (NIH) has awarded grants to seven UC San Francisco scientists to pursue innovative approaches to major contemporary challenges in biomedical research.

UCSF Helen Diller Family Comprehensive Cancer Center Joins National Effort to Improve Survival for Pancreatic Cancer Patients

UCSF Helen Diller Family Comprehensive Cancer Center Joins National Effort to Improve Survival for Pancreatic Cancer Patients

October 4, 2016

The UCSF Helen Diller Family Comprehensive Cancer Center is one of only 12 academic centers in the U.S. joining a large national precision medicine study that aims to improve survival for pancreatic cancer patients.

‘Cellbots’ Chase Down Cancer, Deliver Drugs Directly to Tumors

‘Cellbots’ Chase Down Cancer, Deliver Drugs Directly to Tumors

September 29, 2016

UC San Francisco scientists have engineered human immune cells that can precisely locate diseased cells anywhere in the body and execute a wide range of customizable responses, including the delivery of drugs or other therapeutic payloads directly to tumors or other unhealthy tissues.